What Does Xencor Do?

Total employees283
HeadquartersMonrovia
Founded1997

Xencor, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases. The company's proprietary XmAb® technology enables the creation of diverse antibody and cytokine structures with improved therapeutic properties. Xencor's pipeline includes multiple clinical-stage candidates targeting a range of indications, developed both internally and through strategic collaborations with leading pharmaceutical companies. They are committed to translating innovative science into life-changing therapies for patients with unmet medical needs.

Where Is Xencor's Headquarters?

Xencor officeXencor officeXencor officeXencor office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the primary hub for Xencor's research and development, clinical operations, corporate administration, and strategic leadership.

Notable Features:

Features state-of-the-art laboratory facilities for antibody engineering, protein production, and preclinical research, alongside modern office spaces designed to foster collaboration and innovation.

Work Culture:

Xencor fosters a science-driven, innovative, and collaborative work environment. Employees are often passionate about drug discovery and development, with a strong emphasis on teamwork, scientific rigor, and a patient-focused mission.

HQ Significance:

The Monrovia headquarters is central to Xencor's operations, housing the core scientific and business functions that drive the company's XmAb® technology platform and pipeline development.

Values Reflected in HQ: The headquarters likely reflects Xencor's commitment to innovation, scientific excellence, and efficiency in developing novel therapeutics.

Location:

While Xencor's primary physical operations and headquarters are in California, USA, its impact is global. The company conducts clinical trials for its therapeutic candidates in multiple countries, collaborating with international research institutions and contract research organizations. Furthermore, Xencor engages in strategic partnerships and licensing agreements with pharmaceutical companies worldwide, extending the reach of its XmAb® technology and drug candidates to a global patient population.

Street Address:

111 West Lemon Avenue

City:

Monrovia

State/Province:

California

Country:

USA

Where Else Does Xencor Operate Around the World?

San Diego, California/USA

Address: 9880 Campus Point Dr, San Diego, CA 92121, USA

To leverage the rich biotech ecosystem, academic collaborations, and specialized workforce available in the San Diego area, enhancing Xencor's R&D capabilities.

Buying Intent Signals for Xencor

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Xencor? Meet the Executive Team

As of April 2025, Xencor' leadership includes:

Bassil I. Dahiyat, Ph.D. - President & Chief Executive Officer
John R. Desjarlais, Ph.D. - Senior Vice President, Research & Chief Scientific Officer
John J. Kuch, CPA - Senior Vice President & Chief Financial Officer
Allen Yang, M.D., Ph.D. - Senior Vice President & Chief Medical Officer
Nancy L. Lizzul, M.D., M.B.A., M.P.H. - Senior Vice President, Clinical Development
Christal M.M. Folkes, J.D. - Vice President, General Counsel & Corporate Secretary

Who's Investing in Xencor?

Xencor has been backed by several prominent investors over the years, including:

BlackRock
The Vanguard Group
State Street Corporation
EcoR1 Capital, LLC
Wellington Management Group LLP
RA Capital Management
Artisan Partners Limited Partnership

What Leadership Changes Has Xencor Seen Recently?

Hire0
Exits0

Xencor's core C-suite executive leadership has shown stability over the past 12 months with no major publicly announced departures. There was a key promotion within the senior leadership team.

New Appointments:

John J. Kuch, CPA, John J. Kuch was promoted to Senior Vice President and Chief Financial Officer from his prior role as Vice President, Finance and Chief Accounting Officer.

What Technology (Tech Stack) Is Used byXencor?

Discover the tools Xencor uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Xencor Email Formats and Examples

Xencor commonly uses the [first_initial][last] email format (e.g., jdoe@xencor.com). Other potential formats, though less common, might include [first].[last]@xencor.com.

[first_initial][last]@xencor.com

Format

bdahiyat@xencor.com

Example

90%

Success rate

What's the Latest News About Xencor?

Xencor Investor Relations • May 7, 2024

Xencor Reports First Quarter 2024 Financial Results and Provides Corporate Update

Xencor announced its financial results for the first quarter ended March 31, 2024, and provided a corporate update on its clinical programs, including progress with vudalimab and plamotamab, and its XmAb® BAP platform....more

Xencor Investor Relations • April 8, 2024

Xencor Presents New Preclinical Data from XmAb® Bispecific NK Cell Engager Programs at AACR Annual Meeting 2024

Xencor presented preclinical data on its XmAb natural killer (NK) cell engager programs at the American Association for Cancer Research (AACR) Annual Meeting 2024, highlighting potent anti-tumor activity and potential for improved safety profiles....more

Xencor Investor Relations • February 27, 2024

Xencor Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update

Xencor reported its financial results for the fourth quarter and full year ended December 31, 2023, detailing research and development progress, pipeline advancements, and collaborations....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Xencor, are just a search away.